Nevirapine

Role

Indications

Reactions

Primary

Hiv Infection	49.1%
Human Immunodeficiency Virus Transmission	20.3%
Prophylaxis	18.2%
Prophylaxis Against Hiv Infection	4.1%
Tuberculosis	1.8%
Acquired Immunodeficiency Syndrome	1.5%
Hiv Test Positive	1.2%
Drug Exposure During Pregnancy	0.9%
Antiretroviral Therapy	0.6%
Product Used For Unknown Indication	0.3%
Maternal Exposure During Pregnancy	0.3%
Hiv Infection Who Clinical Stage I	0.2%
Hypertension	0.2%
Retroviral Infection	0.2%
Pneumocystis Jiroveci Pneumonia	0.2%
Deep Vein Thrombosis	0.2%
Meningitis Cryptococcal	0.2%
Menorrhagia	0.2%
Pneumonia	0.2%
Disseminated Tuberculosis	0.1%

Viral Mutation Identified	19.8%
Hiv Infection	18.3%
Human Immunodeficiency Virus Transmission	7.3%
Death	6.5%
Rash	5.3%
Hiv Test Positive	5.0%
Tuberculosis	4.5%
Stillbirth	4.4%
Vomiting	3.4%
Stevens-johnson Syndrome	3.2%
Drug Ineffective	3.1%
Varices Oesophageal	2.9%
Hyperlactacidaemia	2.3%
Pre-eclampsia	2.1%
Skin Toxicity	2.1%
Weight Decreased	2.1%
Hepatotoxicity	1.9%
Immune Reconstitution Syndrome	1.9%
Small For Dates Baby	1.9%
Pneumonia	1.8%

Secondary

Hiv Infection	51.0%
Human Immunodeficiency Virus Transmission	9.4%
Prophylaxis	9.3%
Prophylaxis Against Hiv Infection	4.7%
Drug Exposure During Pregnancy	4.4%
Antiretroviral Therapy	4.1%
Antiviral Prophylaxis	3.6%
Drug Use For Unknown Indication	3.2%
Acquired Immunodeficiency Syndrome	1.4%
Product Used For Unknown Indication	1.4%
Tuberculosis	1.3%
Antifungal Prophylaxis	1.1%
Hiv Test Positive	1.1%
Systemic Antiviral Treatment	0.7%
Chest Discomfort	0.6%
Pain In Extremity	0.6%
Factor Viii Deficiency	0.6%
Antiviral Treatment	0.5%
Diarrhoea	0.5%
Hepatitis C	0.5%

Viral Mutation Identified	12.3%
Hiv Infection	11.0%
Vomiting	8.8%
Weight Decreased	7.4%
Pregnancy	6.5%
Stillbirth	6.3%
Drug Exposure During Pregnancy	5.6%
Progressive External Ophthalmoplegia	5.4%
Human Immunodeficiency Virus Transmission	4.3%
Maternal Drugs Affecting Foetus	4.1%
Stevens-johnson Syndrome	3.4%
Death	3.2%
Hiv Test Positive	3.2%
Portal Hypertension	3.2%
Tuberculosis	2.9%
Vanishing Bile Duct Syndrome	2.7%
Small For Dates Baby	2.5%
White Blood Cell Count Decreased	2.5%
Abortion Spontaneous	2.3%
Anaemia	2.3%

Concomitant

Hiv Infection	61.4%
Drug Use For Unknown Indication	9.0%
Product Used For Unknown Indication	7.3%
Antiretroviral Therapy	3.6%
Drug Exposure During Pregnancy	3.0%
Prophylaxis	2.1%
Prophylaxis Against Hiv Infection	1.8%
Hiv Test Positive	1.5%
Neuropathy Peripheral	1.4%
Antiviral Prophylaxis	1.3%
Tuberculosis	1.2%
Depression	0.9%
Hypertension	0.7%
Pelvic Inflammatory Disease	0.7%
Skin Lesion	0.7%
Lymphoma	0.7%
Isosporiasis	0.7%
Human Immunodeficiency Virus Transmission	0.6%
Vitamin Supplementation	0.6%
Acquired Immunodeficiency Syndrome	0.6%

Pregnancy	9.9%
Drug Exposure During Pregnancy	7.9%
Weight Decreased	7.0%
Premature Baby	6.6%
Abortion Spontaneous	6.2%
Stillbirth	6.2%
Vomiting	6.2%
Drug Interaction	5.4%
Pyrexia	5.4%
Renal Failure Acute	4.1%
Suicidal Ideation	4.1%
Panic Attack	3.7%
Renal Failure	3.7%
Thrombocytopenia	3.7%
Death	3.3%
Drug Resistance	3.3%
Lipodystrophy Acquired	3.3%
Osteonecrosis	3.3%
Rectal Cancer	3.3%
Tremor	3.3%

Interacting

Hiv Infection	27.5%
Acquired Immunodeficiency Syndrome	18.8%
Antiretroviral Therapy	12.5%
Hypercholesterolaemia	6.3%
Lower Respiratory Tract Infection	6.3%
Acne	5.0%
Dysmenorrhoea	5.0%
Menorrhagia	5.0%
Immunosuppression	3.8%
Knee Arthroplasty	3.8%
Thrombosis Prophylaxis	3.8%
Hiv Test Positive	1.3%
Renal Transplant	1.3%